VanEck Pharmaceutical ETF
PPH
PPH
101 hedge funds and large institutions have $391M invested in VanEck Pharmaceutical ETF in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 106 → 101 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Holders
101
Holding in Top 10
1
Calls
$780K
Puts
$254K
Top Buyers
| 1 | +$23.7M | |
| 2 | +$18.6M | |
| 3 | +$11.5M | |
| 4 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
+$11.2M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$8.86M |
Top Sellers
| 1 | -$38.1M | |
| 2 | -$5.21M | |
| 3 | -$2.8M | |
| 4 |
SIM
Seaview Investment Managers
Miami,
Florida
|
-$2.04M |
| 5 |
AC
ASB Consultores
Aventura,
Florida
|
-$1.88M |